Details for Patent: 5,597,815
✉ Email this page to a colleague
Summary for Patent: 5,597,815
Title: | Prevention of hyperphosphatemia in kidney disorder patients |
Abstract: | The 19-nor-vitamin D analogs, and particularly 19-nor-1.alpha.,25-dihydroxyvitamin D.sub.2, possess low calcemic and phosphatemic activity while also having the ability to suppress parathyroid hormone (PTH) production. The suppressive effect on PTH secretion of these 19-nor analogs without significant changes in serum calcium or serum phosphorus make them ideal tools for the treatment of secondary hyperparathyroidism in patients having kidney disorders. |
Inventor(s): | Deluca; Hector F. (Deerfield, WI), Slatopolsky; Eduardo (St. Louis, MO) |
Assignee: | Wisconsin Alumni Research Foundation (Madison, WI) |
Application Number: | 08/502,288 |
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; | More… ↓ |
Drugs Protected by US Patent 5,597,815
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,597,815
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 290868 | ⤷ Subscribe | |||
Australia | 6636496 | ⤷ Subscribe | |||
Australia | 705895 | ⤷ Subscribe | |||
Canada | 2224284 | ⤷ Subscribe | |||
Germany | 69634483 | ⤷ Subscribe | |||
Denmark | 0837681 | ⤷ Subscribe | |||
European Patent Office | 0837681 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |